WILSON TROY EDWARD sold 15.3% of their position (10.80K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $77.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/16/2026ACC: 0001437749-26-020709
Director
Since Jun 2019
+16.20K
Net shares
Net buyer
$77.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
27K acquired · 10.80K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+27K
Price / share
—
Trade value
—
% of position
62.0%
6/11/2026
43.55K→70.55K
Common Stock
Direct
Shares
−10.80K
Price / share
$7.20
Trade value
$77.75K
% of position
15.3%
6/12/2026
70.55K→59.75K
Total
Net shares
+16.20K
Net value
-$77.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | A · Award | +27K | — | — | 62.0% | 43.55K | 70.55K |
| Common Stock Direct | 6/12/2026 | S · Sale | −10.80K | $7.20 | $77.75K | 15.3% | 70.55K | 59.75K |
| Total | +16.20K | -$77.75K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned150.00
Common Stock
IndirectShares owned400.00
Total
550.00 indirect550.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 150.00 | Indirect |
| Common Stock | 400.00 | Indirect |
| Total | 550.00 | 550.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported